16 studies found for:    Pulmonary Embolism | Open Studies | NIH, U.S. Fed
Hide Display Options

Display Options

Study Details
Participant Details
Identifiers
Dates
Rank Status Study
1 Unknown  Assessing the Prognosis of Pulmonary Embolism Using Clinical and Imaging Biomarkers (Retrospective & Prospective )
Condition: Pulmonary Embolism
Intervention:
2 Not yet recruiting Efficacy of Low (30ml) Versus Full Dose (100ml) Contrast CT Pulmonary Angiography in Detecting Emboli
Condition: Multiple Pulmonary Emboli
Interventions: Procedure: Low-Dose IV Contrast;   Device: Siemens Sensation 64-MDCT scanner.;   Drug: Visipaque 320 non-ionic isoosmolar contrast agent
3 Unknown  Modeling Genotype and Other Factors to Enhance the Safety of Coumadin Prescribing
Conditions: Atrial Fibrillation;   Deep Venous Thrombosis;   Heart Valve Replacement;   Pulmonary Embolism
Intervention: Drug: Coumadin
4 Recruiting Development of Computer-aided Detection and Diagnosis From Imaging Techniques
Condition: Cancer
Intervention:
5 Recruiting The Spot Sign for Predicting and Treating ICH Growth Study
Condition: Intracerebral Hemorrhage
Interventions: Drug: recombinant activated factor VII;   Drug: placebo
6 Recruiting Pharmacogenetics of Warfarin in Puerto Ricans.
Conditions: Atrial Fibrillation;   Deep Vein Thrombosis;   Cardiac Valvular Insufficiency;   Antiphospholipid Syndrome;   Coagulopathy
Intervention:
7 Recruiting A Randomized Trial of Induction Versus Expectant Management
Condition: Labor and Delivery
Intervention: Procedure: Elective Induction of Labor
8 Recruiting Blood Markers of Inflammation, Blood Clotting and Blood Vessel Function in HIV-infected Adults
Conditions: Cardiovascular Disease;   HIV Infections
Intervention:
9 Recruiting Effectiveness of Bridging Anticoagulation for Surgery (The BRIDGE Study)
Conditions: Arterial Thromboembolic Events;   Atrial Fibrillation
Interventions: Drug: Placebo;   Drug: Dalteparin
10 Recruiting Acute Venous Thrombosis: Thrombus Removal With Adjunctive Catheter-Directed Thrombolysis
Conditions: Deep Vein Thrombosis;   Venous Thrombosis;   Postphlebitic Syndrome;   Venous Thromboembolism;   Post Thrombotic Syndrome
Intervention: Drug: Recombinant tissue plasminogen activator (rt-PA)
11 Recruiting Hormone Therapy, Radiation Therapy, and Steroid 17alpha-monooxygenase TAK-700 in Treating Patients With High-Risk Prostate Cancer
Condition: Prostate Cancer
Interventions: Drug: bicalutamide;   Drug: buserelin;   Drug: flutamide;   Drug: goserelin acetate;   Drug: leuprolide acetate;   Drug: orteronel;   Drug: triptorelin
12 Not yet recruiting Prehospital Tranexamic Acid Use for Traumatic Brain Injury
Condition: Traumatic Brain Injury
Interventions: Drug: 1 gram Tranexamic Acid (TXA);   Drug: 2 grams TXA;   Drug: 0.9% Sodium Chloride injectable
13 Not yet recruiting Cancer Associated Thrombosis and Isoquercetin (CAT IQ)
Conditions: Thromboembolism of Vein VTE in Colorectal Cancer;   Thromboembolism of Vein in Pancreatic Cancer;   Thromboembolism of Vein in Non-small Cell Lung Cancer
Intervention: Drug: Isoquercetin
14 Unknown  The Inhibition of Platelet Antiaggregating Activity of Clopidogrel by Atorvastatin Detected by Erythromycin Breath Test: a Metabolic Inhibition of Hepatic Cytochrome P450-3A
Conditions: Hypercholesterolemia;   Thrombosis
Interventions: Drug: Clopidogrel;   Drug: Atorvastatin
15 Recruiting Genetics Informatics Trial (GIFT) of Warfarin to Prevent DVT
Condition: Thromboembolism
Interventions: Genetic: Pharmacogenetic Warfarin Initiation;   Other: Clinical Warfarin Initiation
16 Unknown  Predictors of Anticoagulation Control on Warfarin Therapy
Conditions: Atrial Fibrillation;   Deep Vein Thrombosis;   Heart Valve Replacement
Intervention:

Indicates status has not been verified in more than two years